Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for EYPT

Stock Name	Eyepoint Pharmaceuticals Inc
Ticker	EYPT(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US30233G2093
LEI	549300QE1RU34T50MR69

Show aggregate EYPT holdings

News associated with EYPT

Brokerages Set Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Target Price at $26.86: Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has been given an average recommendation of “Buy” by the seven analysts that are presently covering the company, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have updated their coverage on the stock […] - 2025-09-22 02:42:50
Brokerages Set Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Price Target at $25.38: Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has earned a consensus recommendation of “Buy” from the eight ratings firms that are covering the firm, MarketBeat Ratings reports. Eight research analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have covered the stock in the last year […] - 2025-08-28 03:12:50
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Down After Earnings Miss: Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) gapped down before the market opened on Wednesday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $10.89, but opened at $9.82. Eyepoint Pharmaceuticals shares last traded at $10.42, with a volume of 189,142 shares trading hands. The company reported ($0.85) […] - 2025-08-08 02:44:51
Royal Bank Of Canada Begins Coverage on Eyepoint Pharmaceuticals (NASDAQ:EYPT): Equities research analysts at Royal Bank Of Canada began coverage on shares of Eyepoint Pharmaceuticals (NASDAQ:EYPT – Get Free Report) in a research report issued on Tuesday, Marketbeat reports. The firm set an “outperform” rating and a $28.00 price target on the stock. Royal Bank Of Canada’s price objective would suggest a potential upside of […] - 2025-06-19 02:42:47
Two Sigma Advisers LP Decreases Position in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT): Two Sigma Advisers LP cut its stake in shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 37.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 104,500 shares of the company’s stock after selling 62,000 shares during […] - 2025-06-03 05:00:52
Two Sigma Investments LP Sells 103,098 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT): Two Sigma Investments LP reduced its stake in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 22.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 353,954 shares of the company’s stock after selling 103,098 shares during the quarter. Two […] - 2025-06-01 05:52:45
EyePoint Pharmaceuticals (NASDAQ:EYPT) Price Target Lowered to $26.00 at Mizuho: EyePoint Pharmaceuticals (NASDAQ:EYPT – Free Report) had its price objective decreased by Mizuho from $30.00 to $26.00 in a research note published on Friday,Benzinga reports. Mizuho currently has an outperform rating on the stock. A number of other equities analysts also recently issued reports on the stock. StockNews.com upgraded shares of EyePoint Pharmaceuticals to a […] - 2025-05-19 02:46:48
Tower Research Capital LLC TRC Cuts Stock Position in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT): Tower Research Capital LLC TRC cut its stake in shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 53.4% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 4,581 shares of the company’s stock after selling 5,241 shares during the period. Tower Research Capital LLC TRC’s holdings […] - 2025-05-15 05:38:48
Schonfeld Strategic Advisors LLC Acquires New Holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT): Schonfeld Strategic Advisors LLC acquired a new stake in shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 12,200 shares of the company’s stock, valued at approximately $91,000. Other hedge funds and other […] - 2025-05-15 04:56:50
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Shares Sold by Renaissance Technologies LLC: Renaissance Technologies LLC reduced its position in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 26.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 137,500 shares of the company’s stock after selling 49,937 shares during the period. Renaissance Technologies LLC’s holdings in […] - 2025-05-01 05:31:09
Legal & General Group Plc Boosts Stock Holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT): Legal & General Group Plc grew its position in shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 4.4% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 46,263 shares of the company’s stock after purchasing an additional 1,932 shares during the period. Legal & General Group Plc’s holdings in EyePoint Pharmaceuticals were […] - 2025-05-01 04:45:01
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives $26.63 Average Target Price from Analysts: EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has received a consensus rating of “Buy” from the nine ratings firms that are presently covering the stock, MarketBeat reports. Nine analysts have rated the stock with a buy recommendation. The average 1 year price target among brokers that have updated their coverage on the stock in […] - 2025-04-25 02:52:46
Wellington Management Group LLP Acquires 5,552 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT): Wellington Management Group LLP lifted its holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 3.2% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 177,316 shares of the company’s stock after buying an additional 5,552 shares during the period. Wellington Management Group LLP’s holdings in EyePoint Pharmaceuticals were worth $1,321,000 at the […] - 2025-04-14 04:50:52
Brokerages Set EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) PT at $26.63: EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has received a consensus rating of “Buy” from the nine brokerages that are currently covering the firm, MarketBeat.com reports. Nine equities research analysts have rated the stock with a buy rating. The average 1 year price objective among brokerages that have issued a report on the stock […] - 2025-03-31 02:46:59
Intech Investment Management LLC Acquires 6,137 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT): Intech Investment Management LLC boosted its holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 36.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 23,105 shares of the company’s stock after buying an additional 6,137 shares during the quarter. Intech Investment Management […] - 2025-03-28 06:30:47
China Universal Asset Management Co. Ltd. Has $108,000 Holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT): China Universal Asset Management Co. Ltd. grew its stake in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 40.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,472 shares of the company’s stock after buying an additional 4,179 shares during the quarter. China Universal […] - 2025-02-04 07:14:53

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) EYPT holdings

Date	Number of EYPT Shares Held	Base Market Value of EYPT Shares	Local Market Value of EYPT Shares	Change in EYPT Shares Held	Change in EYPT Base Value	Current Price per EYPT Share Held	Previous Price per EYPT Share Held
2025-12-03 (Wednesday)	47,954	USD 696,292	USD 696,292	0	USD 39,802	USD 14.52	USD 13.69
2025-12-02 (Tuesday)	47,954	USD 656,490	USD 656,490	1,725	USD -2,736	USD 13.69	USD 14.26
2025-12-01 (Monday)	46,229	USD 659,226	USD 659,226	0	USD -26,350	USD 14.26	USD 14.83
2025-11-28 (Friday)	46,229	USD 685,576	USD 685,576	115	USD 3,550	USD 14.83	USD 14.79
2025-11-27 (Thursday)	46,114	USD 682,026	USD 682,026	0	USD 0	USD 14.79	USD 14.79
2025-11-26 (Wednesday)	46,114	USD 682,026	USD 682,026	345	USD 7,391	USD 14.79	USD 14.74
2025-11-25 (Tuesday)	45,769	USD 674,635	USD 674,635	575	USD 23,841	USD 14.74	USD 14.4
2025-11-24 (Monday)	45,194	USD 650,794	USD 650,794	115	USD 34,113	USD 14.4	USD 13.68
2025-11-21 (Friday)	45,079	USD 616,681	USD 616,681	0	USD 1,803	USD 13.68	USD 13.64
2025-11-20 (Thursday)	45,079	USD 614,878	USD 614,878	-460	USD -35,419	USD 13.64	USD 14.28
2025-11-19 (Wednesday)	45,539	USD 650,297	USD 650,297	114	USD 16,164	USD 14.28	USD 13.96
2025-11-18 (Tuesday)	45,425	USD 634,133	USD 634,133	690	USD 46,539	USD 13.96	USD 13.135
2025-11-17 (Monday)	44,735	USD 587,594	USD 587,594	230	USD 72,226	USD 13.135	USD 11.58

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EYPT by Blackrock for IE00BDZVHG35

Show aggregate share trades of EYPT

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 1,725 14.459 13.610 13.695 USD 23,624 8.84
2025-11-28 BUY 115 14.950 14.640 14.671 USD 1,687 8.79
2025-11-26 BUY 345 14.960 14.260 14.330 USD 4,944 8.73
2025-11-26 BUY 345 14.960 14.260 14.330 USD 4,944 8.73
2025-11-25 BUY 575 14.760 13.860 13.950 USD 8,021 8.70
2025-11-24 BUY 115 14.490 13.750 13.824 USD 1,590 8.67
2025-11-20 SELL -460 14.670 13.550 13.662 USD -6,285 8.62 Loss of -2,321 on sale
2025-11-19 BUY 114 14.640 13.700 13.794 USD 1,573 8.59
2025-11-18 BUY 690 14.551 12.960 13.120 USD 9,052 8.56
2025-11-17 BUY 230 13.270 11.550 11.722 USD 2,696 8.53
2025-11-14 BUY 115 12.035 11.300 11.374 USD 1,308 8.52
2025-11-12 BUY 115 12.215 11.325 11.414 USD 1,313 8.48
2025-11-10 BUY 114 11.780 11.220 11.276 USD 1,285 8.45
2025-11-06 BUY 114 11.750 10.860 10.949 USD 1,248 8.42
2025-11-04 BUY 115 12.950 11.960 12.059 USD 1,387 8.39
2025-10-30 BUY 575 12.250 11.550 11.620 USD 6,682 8.32
2025-10-29 BUY 230 11.730 12.470 12.396 USD 2,851 8.30
2025-10-22 SELL -456 11.450 12.080 12.017 USD -5,480 8.19 Loss of -1,743 on sale
2025-10-20 BUY 228 12.030 12.050 12.048 USD 2,747 8.15
2025-10-17 BUY 569 11.630 11.660 11.657 USD 6,633 8.13
2025-10-15 BUY 904 11.730 13.490 13.314 USD 12,036 8.11
2025-10-03 BUY 805 13.730 14.040 14.009 USD 11,277 8.04
2025-10-02 BUY 115 13.500 13.750 13.725 USD 1,578 8.01
2025-09-30 BUY 230 14.240 14.910 14.843 USD 3,414 7.94
2025-09-26 BUY 230 13.900 14.100 14.080 USD 3,238 7.87
2025-09-25 BUY 230 13.190 14.060 13.973 USD 3,214 7.84
2025-09-18 BUY 122 13.760 13.970 13.949 USD 1,702 7.80
2025-09-17 BUY 369 13.640 14.150 14.099 USD 5,203 7.76
2025-07-17 SELL -242 10.300 10.580 10.552 USD -2,554 7.67 Loss of -697 on sale
2025-07-11 SELL -976 10.360 11.140 11.062 USD -10,797 7.61 Loss of -3,370 on sale
2025-07-02 BUY 6,710 9.660 10.200 10.146 USD 68,080 7.53
2025-06-25 BUY 244 10.540 10.770 10.747 USD 2,622 7.47
2025-06-11 BUY 246 8.810 9.360 9.305 USD 2,289 7.36
2025-06-10 BUY 248 9.210 9.550 9.516 USD 2,360 7.35
2025-06-04 SELL -124 8.200 8.360 8.344 USD -1,035 7.31 Loss of -128 on sale
2025-04-23 BUY 124 6.710 7.000 6.971 USD 864 7.59
2025-04-10 SELL -1,000 4.800 4.850 4.845 USD -4,845 7.78 Profit of 2,936 on sale
2025-04-08 SELL -125 4.130 4.860 4.787 USD -598 7.86 Profit of 384 on sale
2025-04-07 SELL -125 4.620 4.720 4.710 USD -589 7.90 Profit of 398 on sale
2025-04-04 SELL -625 4.610 5.100 5.051 USD -3,157 7.94 Profit of 1,803 on sale
2025-04-01 BUY 4,659 5.050 5.390 5.356 USD 24,954 8.00
2025-03-31 SELL -333 5.420 5.710 5.681 USD -1,892 8.03 Profit of 783 on sale
2025-03-14 SELL -1,792 6.520 7.060 7.006 USD -12,555 8.32 Profit of 2,348 on sale
2025-03-07 SELL -224 7.130 7.450 7.418 USD -1,662 8.40 Profit of 221 on sale
2025-03-04 SELL -112 6.080 6.310 6.287 USD -704 8.50 Profit of 247 on sale
2025-02-25 BUY 224 5.960 6.140 6.122 USD 1,371 8.71
2025-02-19 SELL -112 6.470 6.570 6.560 USD -735 8.89 Profit of 261 on sale
2025-02-13 BUY 333 6.310 6.520 6.499 USD 2,164 9.09
2025-02-12 BUY 111 6.350 6.440 6.431 USD 714 9.14
2025-02-11 BUY 444 6.280 6.470 6.451 USD 2,864 9.20
2024-12-30 BUY 3,958 7.020 7.200 7.182 USD 28,426 9.94
2024-11-18 SELL -1,410 8.580 9.310 9.237 USD -13,024 11.20 Profit of 2,762 on sale
2024-11-08 SELL -94 11.630 11.770 11.756 USD -1,105 11.17 Loss of -55 on sale
2024-10-21 SELL -95 10.700 11.200 11.150 USD -1,059 0.00 Loss of -1,059 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	1,725	14.459	13.610	13.695	USD 23,624	8.84
2025-11-28	BUY	115	14.950	14.640	14.671	USD 1,687	8.79
2025-11-26	BUY	345	14.960	14.260	14.330	USD 4,944	8.73
2025-11-26	BUY	345	14.960	14.260	14.330	USD 4,944	8.73
2025-11-25	BUY	575	14.760	13.860	13.950	USD 8,021	8.70
2025-11-24	BUY	115	14.490	13.750	13.824	USD 1,590	8.67
2025-11-20	SELL	-460	14.670	13.550	13.662	USD -6,285	8.62 Loss of -2,321 on sale
2025-11-19	BUY	114	14.640	13.700	13.794	USD 1,573	8.59
2025-11-18	BUY	690	14.551	12.960	13.120	USD 9,052	8.56
2025-11-17	BUY	230	13.270	11.550	11.722	USD 2,696	8.53
2025-11-14	BUY	115	12.035	11.300	11.374	USD 1,308	8.52
2025-11-12	BUY	115	12.215	11.325	11.414	USD 1,313	8.48
2025-11-10	BUY	114	11.780	11.220	11.276	USD 1,285	8.45
2025-11-06	BUY	114	11.750	10.860	10.949	USD 1,248	8.42
2025-11-04	BUY	115	12.950	11.960	12.059	USD 1,387	8.39
2025-10-30	BUY	575	12.250	11.550	11.620	USD 6,682	8.32
2025-10-29	BUY	230	11.730	12.470	12.396	USD 2,851	8.30
2025-10-22	SELL	-456	11.450	12.080	12.017	USD -5,480	8.19 Loss of -1,743 on sale
2025-10-20	BUY	228	12.030	12.050	12.048	USD 2,747	8.15
2025-10-17	BUY	569	11.630	11.660	11.657	USD 6,633	8.13
2025-10-15	BUY	904	11.730	13.490	13.314	USD 12,036	8.11
2025-10-03	BUY	805	13.730	14.040	14.009	USD 11,277	8.04
2025-10-02	BUY	115	13.500	13.750	13.725	USD 1,578	8.01
2025-09-30	BUY	230	14.240	14.910	14.843	USD 3,414	7.94
2025-09-26	BUY	230	13.900	14.100	14.080	USD 3,238	7.87
2025-09-25	BUY	230	13.190	14.060	13.973	USD 3,214	7.84
2025-09-18	BUY	122	13.760	13.970	13.949	USD 1,702	7.80
2025-09-17	BUY	369	13.640	14.150	14.099	USD 5,203	7.76
2025-07-17	SELL	-242	10.300	10.580	10.552	USD -2,554	7.67 Loss of -697 on sale
2025-07-11	SELL	-976	10.360	11.140	11.062	USD -10,797	7.61 Loss of -3,370 on sale
2025-07-02	BUY	6,710	9.660	10.200	10.146	USD 68,080	7.53
2025-06-25	BUY	244	10.540	10.770	10.747	USD 2,622	7.47
2025-06-11	BUY	246	8.810	9.360	9.305	USD 2,289	7.36
2025-06-10	BUY	248	9.210	9.550	9.516	USD 2,360	7.35
2025-06-04	SELL	-124	8.200	8.360	8.344	USD -1,035	7.31 Loss of -128 on sale
2025-04-23	BUY	124	6.710	7.000	6.971	USD 864	7.59
2025-04-10	SELL	-1,000	4.800	4.850	4.845	USD -4,845	7.78 Profit of 2,936 on sale
2025-04-08	SELL	-125	4.130	4.860	4.787	USD -598	7.86 Profit of 384 on sale
2025-04-07	SELL	-125	4.620	4.720	4.710	USD -589	7.90 Profit of 398 on sale
2025-04-04	SELL	-625	4.610	5.100	5.051	USD -3,157	7.94 Profit of 1,803 on sale
2025-04-01	BUY	4,659	5.050	5.390	5.356	USD 24,954	8.00
2025-03-31	SELL	-333	5.420	5.710	5.681	USD -1,892	8.03 Profit of 783 on sale
2025-03-14	SELL	-1,792	6.520	7.060	7.006	USD -12,555	8.32 Profit of 2,348 on sale
2025-03-07	SELL	-224	7.130	7.450	7.418	USD -1,662	8.40 Profit of 221 on sale
2025-03-04	SELL	-112	6.080	6.310	6.287	USD -704	8.50 Profit of 247 on sale
2025-02-25	BUY	224	5.960	6.140	6.122	USD 1,371	8.71
2025-02-19	SELL	-112	6.470	6.570	6.560	USD -735	8.89 Profit of 261 on sale
2025-02-13	BUY	333	6.310	6.520	6.499	USD 2,164	9.09
2025-02-12	BUY	111	6.350	6.440	6.431	USD 714	9.14
2025-02-11	BUY	444	6.280	6.470	6.451	USD 2,864	9.20
2024-12-30	BUY	3,958	7.020	7.200	7.182	USD 28,426	9.94
2024-11-18	SELL	-1,410	8.580	9.310	9.237	USD -13,024	11.20 Profit of 2,762 on sale
2024-11-08	SELL	-94	11.630	11.770	11.756	USD -1,105	11.17 Loss of -55 on sale
2024-10-21	SELL	-95	10.700	11.200	11.150	USD -1,059	0.00 Loss of -1,059 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EYPT

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	144,311	0	478,781	30.1%
2025-09-18	61,555	0	157,382	39.1%
2025-09-17	153,958	0	310,194	49.6%
2025-09-16	174,952	100	313,037	55.9%
2025-09-15	102,427	2	477,693	21.4%
2025-09-12	151,134	0	285,333	53.0%
2025-09-11	123,312	0	726,029	17.0%
2025-09-10	214,378	600	344,320	62.3%
2025-09-09	349,506	701	534,859	65.3%
2025-09-08	182,539	193	398,314	45.8%
2025-09-05	401,029	1,301	872,730	46.0%
2025-09-04	150,527	0	204,033	73.8%
2025-09-03	119,579	0	152,251	78.5%
2025-09-02	93,485	600	125,232	74.6%
2025-08-29	85,128	0	126,076	67.5%
2025-08-28	100,092	0	159,660	62.7%
2025-08-27	113,575	0	195,498	58.1%
2025-08-26	84,377	3,285	103,081	81.9%
2025-08-25	146,067	0	181,258	80.6%
2025-08-22	151,702	300	227,733	66.6%
2025-08-21	150,509	0	200,664	75.0%
2025-08-20	243,888	7,193	433,209	56.3%
2025-08-19	98,626	158	328,646	30.0%
2025-08-18	152,838	7,300	322,185	47.4%
2025-08-15	159,787	0	278,105	57.5%
2025-08-14	411,427	0	538,423	76.4%
2025-08-13	207,606	4,811	338,946	61.3%
2025-08-12	195,609	704	281,160	69.6%
2025-08-11	91,269	141	183,862	49.6%
2025-08-08	116,484	424	138,705	84.0%
2025-08-07	268,930	3,232	334,200	80.5%
2025-08-06	254,094	5,239	397,462	63.9%
2025-08-05	266,307	120	367,711	72.4%
2025-08-04	121,545	710	192,292	63.2%
2025-08-01	112,157	0	150,787	74.4%
2025-07-31	144,373	0	175,668	82.2%
2025-07-30	102,233	0	139,093	73.5%
2025-07-29	85,394	0	118,639	72.0%
2025-07-28	102,412	0	123,053	83.2%
2025-07-25	83,325	0	112,605	74.0%
2025-07-24	127,405	0	225,252	56.6%
2025-07-23	68,751	0	172,486	39.9%
2025-07-22	82,797	0	166,455	49.7%
2025-07-21	155,571	408	213,134	73.0%
2025-07-18	181,052	0	261,114	69.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE